Skip to Main Content

Paper Details

Serial assessment of biomarkers and the risk of stroke or systemic embolism and bleeding in patients with atrial fibrillation in the ENGAGE AF-TIMI 48 trial.
Eur Heart J
24
2021
AF, GDF-15, N, NT-proBNP, S/SEE, atrial fibrillation, bleeding, edoxaban, factor Xa, growth differentiation factor-15, haemoglobin, high-sensitivity troponin T, hsTnT, patients, stroke, systemic embolic events, systemic embolism, transient ischaemic attack
Author NameAffiliation
Robert P GiuglianoBrigham and Women's Hospital, Harvard Medical School
Elliott M AntmanBrigham and Women's Hospital, Harvard Medical School
Eugene BraunwaldBrigham and Women's Hospital, Harvard Medical School
David A MorrowBrigham and Women's Hospital, Harvard Medical School
David A MorrowBrigham and Women's Hospital, Harvard Medical School
  • 1 - 5

Datasets

Release 1.2